Ultragenyx Pharmaceutical(RARE) - 2024 Q3 - Earnings Call Presentation

ultrageny% Corporate Presentation November 2024 Confidential and Proprietary Forward Looking Statements Cautionary note regarding forward-looking statements: This presentation contains forward-looking statements, including, but not limited to, statements regarding our expectations and projections regarding our future operating results and financial performance, anticipated cost or expense reductions, plans with respect to commercializing our product and product candidates, our translational research program ...